# CAcTUS - Circulating Tumour DNA Guided Switch

> **NCT03808441** · PHASE2 · UNKNOWN · sponsor: **The Christie NHS Foundation Trust** · enrollment: 21 (actual)

## Conditions studied

- Melanoma

## Interventions

- **OTHER:** ctDNA analysis

## Key facts

- **NCT ID:** NCT03808441
- **Lead sponsor:** The Christie NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-02
- **Primary completion:** 2023-04-26
- **Final completion:** 2024-05-02
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2023-08-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03808441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03808441, "CAcTUS - Circulating Tumour DNA Guided Switch". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03808441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*